MARKET

DRUG

DRUG

Bright Minds Biosciences Inc
NASDAQ
51.80
-1.71
-3.20%
After Hours: 51.80 0 0.00% 19:30 09/25 EDT
OPEN
53.33
PREV CLOSE
53.51
HIGH
54.37
LOW
51.41
VOLUME
210.97K
TURNOVER
--
52 WEEK HIGH
123.75
52 WEEK LOW
48.90
MARKET CAP
510.96M
P/E (TTM)
-25.3412
1D
5D
1M
3M
1Y
5Y
1D
Bright Minds Biosciences (DRUG) Receives a Rating Update from a Top Analyst
TipRanks · 3d ago
Weekly Report: what happened at DRUG last week (0914-0918)?
Weekly Report · 4d ago
Piper Sandler Sticks to Its Buy Rating for Bright Minds Biosciences (DRUG)
TipRanks · 09/17 12:45
Weekly Report: what happened at DRUG last week (0907-0911)?
Weekly Report · 09/14 09:21
FDA names acting heads of drug and vaccine units to permanent roles
Seeking Alpha · 09/09 00:25
Weekly Report: what happened at DRUG last week (0831-0904)?
Weekly Report · 09/07 09:20
Bright Minds Biosciences to Present at Upcoming Conferences
Barchart · 09/04 15:30
Weekly Report: what happened at DRUG last week (0824-0828)?
Weekly Report · 08/31 09:22
More
About DRUG
Bright Minds Biosciences Inc. is a biotechnology company, which is engaged in developing treatments for patients with neurological and psychiatric disorders. The Company is focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, depression, and other central nervous system (CNS) disorders. Its Serotonin (5-HT) is a neurotransmitter in the brain and modulates many biological functions. Dysfunction of serotonin receptors, transporters, and associated neurocircuits is fundamental to many diseases including epilepsies and neuro psychiatric. Its pipeline includes BMB-101, BMB-xxx, BMB-201, and BMB-202. The Company has a portfolio of patented, selective serotonin (5-HT2C, 5-HT2A and 5-HT2C/A-receptor subtypes) agonists that were identified by using high-throughput screening methods in combination with advanced molecular modeling techniques to interrogate the interaction between the drug and its targeted receptors to increase downstream signaling.

Webull offers Bright Minds Biosciences Inc stock information, including NASDAQ: DRUG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DRUG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DRUG stock methods without spending real money on the virtual paper trading platform.